Key facts
- This page summarizes George Renaudin II's Form 4 filing for HUMANA INC (HUM).
- 5 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 17 Dec 2025, 09:35.
George Renaudin II - 15 Dec 2025 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- President, Insurance
- Issuer ticker
- HUM
- Reported as of
- 15 Dec 2025
- Net transaction value
- -$262,591
- SEC form
- 4
- Accepted by SEC
- 17 Dec 2025, 09:35:14 UTC
- Prior SEC filing
- 03 Oct 2025
- Next SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- George Renaudin II
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
George Renaudin II filed Form 4 for HUMANA INC (HUM) on 17 Dec 2025.
Change
- Previous filing in this sequence was filed on 03 Oct 2025.
- Current net transaction value: -$262,591.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001964078
Primary reporting owner
Renaudin George II
- Relationship
- President, Insurance
- Address
- HUMANA INC., 500 W. MAIN STREET, LOUISVILLE
- Signature
- George Renaudin II
- Signature date
- 17 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
transaction
Humana Common
Options Exercise
- Transaction value
- $0
- Shares
- +2,106
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 16,071
- Date
- 15 Dec 2025
- Ownership
- Direct
HUM
transaction
Humana Common
Tax liability
- Transaction value
- $224,229
- Shares
- -830
- Change %
- -5.2%
- Price
- $270.16
- Shares after
- 15,241
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F8
HUM
transaction
Humana Common
Options Exercise
- Transaction value
- $0
- Shares
- +360
- Change %
- +2.4%
- Price
- $0.000000
- Shares after
- 15,601
- Date
- 15 Dec 2025
- Ownership
- Direct
HUM
transaction
Humana Common
Tax liability
- Transaction value
- $38,362
- Shares
- -142
- Change %
- -0.91%
- Price
- $270.16
- Shares after
- 15,459
- Date
- 15 Dec 2025
- Ownership
- Direct
- Footnotes
- F6, F8
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 525
- Date
- 15 Dec 2025
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -360
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 360
- Exercise price
- Footnotes
- F4, F5
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,162
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,162
- Exercise price
- $510.24
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,966
- Date
- 15 Dec 2025
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 6,966
- Exercise price
- $367.21
- Footnotes
- F3
HUM
holding
Derivative
Phantom Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 172
- Date
- 15 Dec 2025
- Ownership
- See Footnote
- Underlying class
- Humana Common
- Underlying amount
- 172
- Exercise price
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Shares held for the benefit of reporting person as of November 30, 2025 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
Footnote F2
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
Footnote F4
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Footnote F5
Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Footnote F6
Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
Footnote F7
Phantom Stock Units held for the benefit of reporting person as of November 30, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.
Footnote F8
Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return.